02671nam 2200613 a 450 991095800920332120251117065754.01-61728-480-7(CKB)2670000000090500(EBL)3020935(SSID)ssj0000470344(PQKBManifestationID)11312432(PQKBTitleCode)TC0000470344(PQKBWorkID)10411156(PQKB)11213554(MiAaPQ)EBC3020935(Au-PeEL)EBL3020935(CaPaEBR)ebr10681073(OCoLC)923664583(BIP)30904820(EXLCZ)99267000000009050020100616d2010 uy 0engur|n|---|||||txtccrInsulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) /Masato Yoneda ... [et al.]1st ed.New York Nova Biomedical Booksc20101 online resource (64 p.)Metabolic diseases--laboratory and clinical researchNovinkaDescription based upon print version of record.1-61668-927-7 Includes bibliographical references and index.NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions.The liver is the first organ to receive nutrients that enter the body via the intestines after a meal, and this organ plays a pivotal role in energy metabolism. This book reviews evidence concerning insulin resistance and NAFLD/NASH as a step towards a comprehensive understanding of the pathophysiology and treatment of NAFLD/NASH.Metabolic diseases--laboratory and clinical research series.Novinka (Series)Fatty liverInsulin resistanceFatty liver.Insulin resistance.616.3/62Yoneda Masato1868116Yoneda Masato1868116MiAaPQMiAaPQMiAaPQBOOK9910958009203321Insulin resistance and nonalcoholic fatty liver disease (NAFLD)4475948UNINA